Alpha Cognition Inc. Comm... (ACOG)
NASDAQ: ACOG
· Real-Time Price · USD
8.00
-0.20 (-2.44%)
At close: Sep 24, 2025, 3:59 PM
8.19
2.37%
After-hours: Sep 24, 2025, 07:32 PM EDT
-2.44% (1D)
| Bid | 7.73 |
| Market Cap | 129.29M |
| Revenue (ttm) | 4.59M |
| Net Income (ttm) | -20.01M |
| EPS (ttm) | -1.59 |
| PE Ratio (ttm) | -5.03 |
| Forward PE | -7.15 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 8.28 |
| Volume | 34,332 |
| Avg. Volume (20D) | 67,028 |
| Open | 8.10 |
| Previous Close | 8.20 |
| Day's Range | 7.78 - 8.20 |
| 52-Week Range | 3.75 - 11.54 |
| Beta | 2.70 |
| Ex-Dividend Date | n/a |
About ACOG
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACOG
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACOG stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+27.02%
Alpha Cognition shares are trading higher after th...
Unlock content with
Pro Subscription
8 months ago
+0%
Alpha Cognition shares are trading higher after the company announced a $44 million exclusive licensing agreement for the development and commercialization of ZUNVEYL in Asia, Australia, and New Zealand.
